
Sanofi has promoted Stefan Oelrich to the position of Executive Vice President of Diabetes and Cardiovascular (DCV), giving him a …

The week has flown by and was packed with a number of shocking stories. With the ongoing uncertainty regarding Brexit, …

AbbVie has been stung with a $140 million damages award to a man that suffered a heart attack after using …

New damning allegations have arisen concerning Afghanistan’s pharmaceutical industry, as the Medicine Importers Union claims that at least 40% of …

Bayer, and development partner Janssen, have been forced to stop a Phase 3 trial looking at expanding the indication of …

South Africa’s Competition Commission has admitted that there is no case to be heard against Aspen and Equity, in regards …

Merck KGaA has installed a new head of its healthcare business for the Middle East, Africa and Turkey (MEA) region, …

The ABPI has been knocked back by the UK High Court in its legal challenge to NICE over new drug …

Dr Deborah O’Neil, Chief Executive and Scientific Officer at NovaBiotics, discusses the WHO-recognised threat of ‘super gonorrhoea’ and the antimicrobial …

KSQ Therapeutics has been known of for the last two years, when it was originally founded, but now it has …

In a major change for the healthcare system in England, admittedly one that was easy to be lost among the …

Gilead has announced that it has completed its acquisition of Kite Pharma after the deal was announced on 28 August …

A new study conducted by King’s College London and LSE has found that of 48 treatments approved between 2009 and …

Mylan had been knocked back by the FDA in its quest to have its generic version of Copaxone approved earlier …

AbbVie has expanded the operational capability of its facility located at the Tuas Biomedical Park in Singapore with the addition …

CytomX Therapeutics and Amgen have signed a deal that could be worth a potential $1.5 billion. The agreement will see …

Police have raided the French headquarters of German drug manufacturer Merck KGaA over a scandal concerning its thyroid treatment Levothyrox, …

A new campaign, launched by the WHO, has begun today to reduce deaths from cholera by 90% through to 2030. …

It’s not long since Allergan was in the headlines over its dry-eye drug, Restasis, after an eye-catching attempt to avoid …

As the US continues to be plagued by its opioid crisis, which is claiming the lives of more than 100 …